{"name":"Dyve Biosciences, Inc.","slug":"dyve-biosciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"DYV700","genericName":"DYV700","slug":"dyv700","indication":"Relapsed or refractory acute myeloid leukemia","status":"phase_2"}]}],"pipeline":[{"name":"DYV700","genericName":"DYV700","slug":"dyv700","phase":"phase_2","mechanism":"DYV700 is a small molecule inhibitor of the CDK9 enzyme.","indications":["Relapsed or refractory acute myeloid leukemia"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPNEx3eVdsSzFHVi1MSUxRenZ3TnlNbHBoSVhmVFBEYnJ3V3FIX1d5TlFFNnRqSnJWZTUxc1A1V3hyQnFIYUxfcXRxMHQ1b2x4bHpNWVRGTjNwci1SQ2FLZlVpQUowdHptTkVIQnpqdTNVWk95ck45aUdfRlBYdUo1d1ozQWxEajB5RGxoTWxnNkl5Y0VGZlBYYXMzeERSR1JVZ1B3dkVOREk2TXVNWWxMTFc4RW9iWkNwVWVIYWVrY0VCX2htU3NreHFGS3NvVFRBTk52TnZQTFFYVTlyYW1kaHRteWIyQTl1ZEpMc24yRkstUktTdUg5YzVXdFlVeldVMXFMY1NOZ1o?oc=5","date":"2025-09-16","type":"trial","source":"GlobeNewswire","summary":"Gout Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in Gout Therapeutics | DelveInsight - GlobeNewswire","headline":"Gout Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in Gout Therapeutics | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQa2hkMmdVeHlib0hjN2NIZjdCWWxBbGVmOW5QSnozM3JuUUxFcHhqXzAyVTc3QU1hQXBKUkJTNU1UbmNqcFFQRVB5SFk3TkQ0SFROeUd0V09CQXEwbjNVeFhFNk9VbmRkZzAtSFo4WXFxamlmRnlQeTh5OFdjcXptWks5Rjl4ZkdnQmtJWGdVS2xLc1k0TFRRZkFhYmhDczdIN0QxcWJNZw?oc=5","date":"2022-12-13","type":"trial","source":"today.ucsd.edu","summary":"New Look at an Ancient Disease: Study Finds Novel Treatment Targets for Gout - today.ucsd.edu","headline":"New Look at an Ancient Disease: Study Finds Novel Treatment Targets for Gout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxQVEd5Zmp5U1FsaGhFU2VRZ0ItS0E1VWpXei04TkpkM2N4TXdlUldvdUdWV0hlZHF1X3lxdjB5ME0zSG0wTmJyY2xsaFdzVTgycDB0ekwyZ0VnNHpwamNEVWY1c1dabTc1WW5zX3BfcXR5YnIxQmlNeG1kc1lhaTIwclJEdGJrVnd0VmJrckc5TWM0b3l2QXkxWDJqU3VxVVRURkNKYXpLaktoUHVZZVVNSENxTnRlNndVdUdTWFRJUHlwUVFRWTZHZUxkMUV6OWtkVmQzSHhOVG9fZlFBM3BfMXVaSGtCU1lKckF0T3RrWTB3UQ?oc=5","date":"2021-06-25","type":"deal","source":"GlobeNewswire","summary":"Roth Capital Partners to Host a Virtual Healthcare Private Company Forum on June 28, 2021 - GlobeNewswire","headline":"Roth Capital Partners to Host a Virtual Healthcare Private Company Forum on June 28, 2021","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOcWJ2VmNJbWpldXk1TnNpZzh3UVlnUThleW5hLUpmZ3R0Y0xxNTZvamFDdTVoNnZUdTRhVUpjamlSZWd2bDZzN1hEWWRWbnhRRU1QbHFRbFBpTGtEYUtSRW5DcmZzS3pyTkhwbVp0QjNxaXdaeWNNRGg3SkQzLVZUcXlZeGNscno3X1JEQkZ2TUFpanpO?oc=5","date":"2020-01-08","type":"pipeline","source":"drugdiscoverytrends.com","summary":"Dyve Biosciences hires new chief scientific officer - drugdiscoverytrends.com","headline":"Dyve Biosciences hires new chief scientific officer","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}